Heartflow, Inc. Common Stock
HTFL$29.35
+$0.53 (1.84%)+1.84%
ClosedLoading chart...
IndexN/A
Market Cap2.53B
Enterprise Value10.72B
Income$-0.03B
Sales$0.04B
EmployeesN/A
P/E-14.60
P/S61.03
P/B35.73
P/C-181.94
EV/EBITDA-115.12
EV/SalesN/A
EPS (ttm)-2.01
EarningsN/A
Gross Margin76.80%
Oper. Margin-36.39%
Profit Margin-66.35%
Volume0.82M
Shs Outstand0.09B
Change1.84%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 |
|---|---|---|
| Revenue | $125.81M | $87.17M |
| Cost of Revenue | $31.36M | $29.12M |
| Gross Profit | $94.45M | $58.05M |
| Gross Margin | 75.07% | 66.59% |
| Operating Expenses | $155.67M | $130.97M |
| Operating Income | $-61.22M | $-72.91M |
| Operating Margin | -48.66% | -83.64% |
| Net Income | $-96.43M | $-95.66M |
| Net Margin | -76.65% | -109.73% |
| EPS (Basic) | $-1.49 | $-1.94 |
| EBITDA | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A |
| Price To Sales Ratio | N/A | N/A |
| Shares Outstanding | N/A | N/A |
| Market Capitalization | N/A | N/A |
| Metric | FY 2024 | FY 2023 |
|---|---|---|
| Cash & Short Term Investments | N/A | N/A |
| Short Term Receivables | N/A | N/A |
| Inventories | N/A | N/A |
| Other Current Assets | N/A | N/A |
| Total Current Assets | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A |
| Total Investments and Advances | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A |
| Intangible Assets | N/A | N/A |
| Deferred Tax Assets | N/A | N/A |
| Other Assets | N/A | N/A |
| Total Assets | $118.70M | $185.05M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A |
| Accounts Payable | N/A | N/A |
| Income Tax Payable | N/A | N/A |
| Other Current Liabilities | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long Term Debt | N/A | N/A |
| Provision for Risks Charges | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A |
| Other Liabilities | N/A | N/A |
| Total Liabilities | $978.19M | $962.62M |
| Non-Equity Reserves | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A |
| Common Equity | N/A | N/A |
| Total Shareholders Equity | $-859.48M | $-777.56M |
| Accumulated Minority Interest | N/A | N/A |
| Total Equity | $-859.48M | $-777.56M |
| Total Liabilities & Stockholders Equity | $118.70M | $185.05M |
| Book Value Per Share | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A |
| Full-Time Employees | N/A | N/A |
| Price to Book Ratio | N/A | N/A |
| Return on Assets | N/A | N/A |
| Return on Equity | N/A | N/A |
| Return on Invested Capital | N/A | N/A |
| Quick Ratio | N/A | N/A |
| Current Ratio | N/A | N/A |
| Metric | FY 2024 | FY 2023 |
|---|---|---|
| Net Income | $-96.43M | $-95.66M |
| Depreciation | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A |
| Funds from Operations | N/A | N/A |
| Extraordinary Item | N/A | N/A |
| Changes in Working Capital | N/A | N/A |
| Income Taxes Payable | N/A | N/A |
| Cash from Operating Activities | $-69.00M | $-76.43M |
| Capital Expenditures | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A |
| Purchase of Investments | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A |
| Other Uses | N/A | N/A |
| Other Sources | N/A | N/A |
| Cash from Investing Activities | N/A | N/A |
| Cash Dividends Paid | N/A | N/A |
| Change in Capital Stock | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A |
| Change in Long Term Debt | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A |
| Cash from Financing Activities | N/A | N/A |
| Exchange Rate Effect | N/A | N/A |
| Net Change in Cash | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A |
Company coverage
Latest news
Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More247wallst.com What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?fool.com HeartFlow: A Premium AI Diagnostics Storyseekingalpha.com New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Managementglobenewswire.com Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?fool.com Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?fool.com HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?fool.com Baron Discovery Fund Q1 2026: Who Moved The Needleseekingalpha.com
Show 12 more stories
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?fool.com Heartflow Q1 Earnings Call Highlightsmarketbeat.com HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcriptseekingalpha.com Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidanceglobenewswire.com Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Moneyfool.com Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors.fool.com Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026globenewswire.com Heartflow, Inc. (NASDAQ:HTFL) Given Average Rating of “Moderate Buy” by Analystsdefenseworld.net Heartflow Files Patent Infringement Lawsuit Against Cleerlyglobenewswire.com Campbell Rogers Sells 64,533 Shares of Heartflow (NASDAQ:HTFL) Stockdefenseworld.net How Decentralized AI is Unlocking Value in Cardiac Diagnosticsprnewswire.com What Investors Should Know About One HeartFlow Insider's $2 Million Stock Salefool.com
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Discover more
You may be interested in